15 Feb 2019
Posted by Andrew Kantor
We’ve got an amazing bill in the legislature this year: HB233, which would ban PBM steering. That’s right: It would prevent PBMs from requiring or “incentivizing” patients to use PBM-owned pharmacies, or even promoting those pharmacies to patients.
Now we need your help.
Sign up to be part of a Pharmacist Advocacy Team. You’ll join our advocacy team and about a dozen other pharmacists at the Gold Dome to meet with legislators and explain why this bill is critical for patients. Our lobbyists do a great job, but nothing is more powerful than a roomful of constituents in white coats.
We’ve got three teams available. Please sign up for one of them — your voice is critical!
The bill would make it easier for physicians to get exceptions from insurance company “try and fail” requirements. Further…
The bill would require a health plan to grant or deny an exception to its drug protocols within 24 hours in an urgent health care situation, and in two business days for a non-urgent case.
And yes, GPhA supports this bill!
Apparently it’s become harder for patients to get buprenorphine (to treat opioid-abuse disorders) than to get the opioids themselves.
From 2007 to 2018, Medicare part D patient access to buprenorphine fell from 89 percent in 2007 to 35 percent in 2018 […] In contrast, patients had a far easier path to opioids. During the same period, Medicare part D plan coverage of opioids jumped from 93 percent to 100 percent coverage, without restrictions, according to researchers.
Electronic cigarettes: They’re a gateway to smoking.
No, they’re a way to quit smoking.
No, they’re a gateway.
No, they’re a tool for quitting.
Gateway!
Tool!
If you’re not sure which is correct, you’re not alone. It’s almost as if there’s nuance to the issue and not just a simple answer.
Instead of “Medicare for All,” one U.S. senator wants to take a less-aggressive approach: Medicare at 50 because people over 50 tend to have higher medical bills and can struggle to afford insurance.
[The Congressional Budget Office] estimated that the premiums for the public plan would be about $7,600 annually — significantly lower than the average $15,300 premium on the Obamacare markets that a 64-year-old currently faces.
What’s notable about this bill is that it has broad bipartisan support: 69 percent of Republicans polled favor allowing Medicare buy-in at age 50 instead of waiting till age 64.
We all know healthcare gets more expensive every year. Interesting note: Over the last 11 years, private insurance companies have seen costs go up 4.4% a year per enrollee, while Medicare’s costs only went up 2.4% per year, and Medicaid paid a mere 1.6% more each year.
Say what you want about the government buying $1,000 screwdrivers, but when it comes to healthcare it’s doing something right.
So you go out for a nice steak dinner with a glass of wine, right? Bad idea. A new Dutch study says that getting too much protein from animals is tied to non-alcoholic fatty liver disease. And that glass of wine? That can up your risk of breast cancer, the WHO reminds us.
Fine, fine, you say — you’ll take a Diet Coke instead. Not so fast. A new study out of the Albert Einstein College of Medicine* finds that diet sodas can increase the risk of stroke, especially in older women.
We’ve all been there — cuddling with a significant other who decides to play a little footsie… with feet that feel like sandpaper. Yeow! Fear not: Arm and Hammer is introducing Heels & Feet Moisturizer (“plus gentle exfoliators”). Coming to your pharmacy soon?